Form 13-F position report

QUALIGEN THERAPEUTICS INC

Reported by STATE STREET CORPORATION

QLGNXXXX CUSIP 74754R202 Manager CIK 0000093751

Reported 0 shares, down 10,930 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 14318
2023-03-31 10112
2023-06-30 9957
2023-09-30 11039
2023-12-31 6012
2024-03-31 4263
2024-06-30 1887
2024-09-30 1864
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for QUALIGEN THERAPEUTICS INC held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -10,930 (-100.0%) 0 $0 2025-02-14
Q3 2024 Unchanged 10,930 0 (0.0%) < 0.01% $1,864 2024-11-14
Q2 2024 Unchanged 10,930 0 (0.0%) < 0.01% $1,887 2024-08-14
Q1 2024 Unchanged 10,930 0 (0.0%) < 0.01% $4,263 2024-05-15
Q4 2023 Unchanged 10,930 0 (0.0%) < 0.01% $6,012 2024-02-14
Q3 2023 Unchanged 10,930 0 (0.0%) < 0.01% $11,039 2023-11-14
Q2 2023 Unchanged 10,930 0 (0.0%) < 0.01% $9,957 2023-08-14
Q1 2023 Unchanged 10,930 0 (0.0%) < 0.01% $10,112 2023-05-15
Q4 2022 New 10,930 +10,930 (0.0%) < 0.01% $14,318 2023-02-14

Who else reported the position

20 managers reported QUALIGEN THERAPEUTICS INC for Q4 2024.

Managers reporting QUALIGEN THERAPEUTICS INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NORTHERN TRUST CORPORATION Reduced 0 -11,899 0 $0 6 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 9 qtrs
Bank of America Corporation Reduced 0 -933 0 $0 5 qtrs
HighMark Wealth Management LLC Reduced 0 -8,009 0 $0 9 qtrs
STATE STREET CORPORATION This report Reduced 0 -10,930 0 $0 9 qtrs
GROUP ONE TRADING L P Reduced 0 -423 0 $0 9 qtrs
ROYAL BANK OF CANADA Reduced 0 -4 0 $0 9 qtrs
US BANCORP DE Reduced 0 -824 0 $0 9 qtrs
SIGNATUREFD LLC Reduced 0 -20 0 $0 2 qtrs
UBS Group AG Reduced 0 -204,509 0 $0 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 14, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.